Tests and tracks treatment for adrenal hormone tumor diseases
Part of Cancer, Hormones & metabolism clinical trials.
This trial studies how adrenal hormone tumor diseases should be diagnosed, treated, and followed over time. It may help people get more precise care and better prediction of outcomes, but it has specific health and medication requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old
- Have one of these adrenal tumor diagnoses: primary aldosteronism, pheochromocytoma, or adrenal cortical cancer
- Be able to give written informed consent and follow study instructions
- Avoid significant kidney problems (creatinine more than 2× the lab’s upper limit)
- Agree not to join if you are pregnant or breastfeeding
- Use of corticosteroid medicines and several heart/stroke timing issues may exclude you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is building a medical database for people with adrenal gland problems like Cushing's syndrome or adrenal tumors. It may help doctors understand these conditions better and improve future care.
This study follows adults with a new adrenal diagnosis to learn how adrenal diseases behave over time. It may help doctors better understand these conditions and improve future care.
This trial studies how to use lab tests (“molecular markers”) in routine clinical care to help manage people with adrenal tumors that could be cancerous. If you are having surgery soon (or recently), your tissue may be tested to see if these markers improve decision-making for your care.
This trial tests a special PET scan that may help doctors find the exact cause of high blood pressure related to an adrenal gland problem. It could help decide if surgery or medicine is the best treatment for you.
This study looks at the genes and molecules in people with primary aldosteronism (a condition where the adrenal glands make too much of the hormone aldosterone), primary hypertension (high blood pressure), and healthy volunteers. The goal is to better understand these conditions and find better ways to diagnose and treat them.
This trial tests two targeted drugs, anlotinib and benmelstobart, for people with advanced pheochromocytoma or paraganglioma that has spread or come back after treatment. These drugs may help shrink tumors or slow their growth.
Hear when a new Complicated Adrenal Tumor Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.